Nuvectis Pharma Inc (NVCT)

EBITDA Growth

-13.62%

Quarterly · Period ending:

NVCT logo

NVCT EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-13.62%
NVCT Quarterly EBITDA YoY % (-12695.65% → -13.62%)
High-resolution chart · PNG

NVCT ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuvectis Pharma Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-13.6249%
-13.4659%
-31.402%
-79.6773%
-43.0443%
-27.8351%
5.6478%
29.3828%
22.4247%
-3.0131%
1.1051%
-0.0681%
-59.9328%
-37.5807%
-196.1521%
-25.8997%
39.8956%
-12,695.6522%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.